Terms: = Colorectal cancer AND PIM1, PIM, 5292, ENSG00000137193, P11309 AND Prognosis
13 results:
1. Dissecting the heterogeneities of the tumor microenvironment between metastatic and nonmetastatic primary colorectal cancer patients by single-cell RNA sequencing.
Wang S; Deng S; Jin X; Chen W; Wang X; Zhan H; Fang X; Fu J
Life Sci; 2023 May; 320():121576. PubMed ID: 36933827
[TBL] [Abstract] [Full Text] [Related]
2. Autoantibodies in the diagnosis, prognosis, and prediction of colorectal cancer.
Niloofa R; De Zoysa MI; Seneviratne LS
J Cancer Res Ther; 2021; 17(4):819-833. PubMed ID: 34528528
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic and immunomodulatory effects of pim1 in colorectal carcinoma.
Zhou Y; Zhou Y; Liu S; Wang J; Ji R; Yan X
J BUON; 2021; 26(2):513-520. PubMed ID: 34077000
[TBL] [Abstract] [Full Text] [Related]
4. Effects of pim3 in prognosis of colon cancer.
Zhou Y; Zhou YN; Liu SX; Wang J; Ji R; Yan X
Clin Transl Oncol; 2021 Oct; 23(10):2163-2170. PubMed ID: 33928496
[TBL] [Abstract] [Full Text] [Related]
5. New Quinoxaline Derivatives as Dual pim-1/2 Kinase Inhibitors: Design, Synthesis and Biological Evaluation.
Oyallon B; Brachet-Botineau M; Logé C; Robert T; Bach S; Ibrahim S; Raoul W; Croix C; Berthelot P; Guillon J; Pinaud N; Gouilleux F; Viaud-Massuard MC; Denevault-Sabourin C
Molecules; 2021 Feb; 26(4):. PubMed ID: 33562106
[TBL] [Abstract] [Full Text] [Related]
6. PAI1 is a Marker of Bad prognosis in Rectal cancer but Predicts a Better Response to Treatment with pim Inhibitor AZD1208.
Muñoz-Galván S; Rivero M; Peinado-Serrano J; Martinez-Pérez J; Fernández-Fernández MC; Ortiz MJ; García-Heredia JM; Carnero A
Cells; 2020 Apr; 9(5):. PubMed ID: 32344898
[TBL] [Abstract] [Full Text] [Related]
7. TAB3 upregulates pim1 expression by directly activating the TAK1-STAT3 complex to promote colorectal cancer growth.
Li Q; Chen L; Luo C; ChenYan ; Ge J; Zhu Z; Wang K; Yu X; Lei J; Liu T; Peng X; Liu X; Yuan R
Exp Cell Res; 2020 Jun; 391(1):111975. PubMed ID: 32229191
[TBL] [Abstract] [Full Text] [Related]
8. pim3 Functions as Oncogenic Factor and Promotes the Tumor Growth and Metastasis in colorectal cancer.
Qi Q; Pan Y; Han S; Liao H; Jiang Y; Shen J; Zhong L; Wang X; Chen J
Anat Rec (Hoboken); 2019 Sep; 302(9):1552-1560. PubMed ID: 30417983
[TBL] [Abstract] [Full Text] [Related]
9. pim1 supports human colorectal cancer growth during glucose deprivation by enhancing the Warburg effect.
Zhang M; Liu T; Sun H; Weng W; Zhang Q; Liu C; Han Y; Sheng W
Cancer Sci; 2018 May; 109(5):1468-1479. PubMed ID: 29516572
[TBL] [Abstract] [Full Text] [Related]
10. Expression of pim-3 in colorectal cancer and its relationship with prognosis.
Zhou Z; Zhang R; Wang R; Zhang Y; Xu L; Chen J; Zhang J; Huang Z; Chen M; Pan Z
Tumour Biol; 2016 Jul; 37(7):9151-6. PubMed ID: 26768612
[TBL] [Abstract] [Full Text] [Related]
11. Multiple effects of the special AT-rich binding protein 1 (SATB1) in colon carcinoma.
Frömberg A; Rabe M; Aigner A
Int J Cancer; 2014 Dec; 135(11):2537-46. PubMed ID: 24729451
[TBL] [Abstract] [Full Text] [Related]
12. Expression of pim-1 in tumors, tumor stroma and tumor-adjacent mucosa co-determines the prognosis of colon cancer patients.
Peng YH; Li JJ; Xie FW; Chen JF; Yu YH; Ouyang XN; Liang HJ
PLoS One; 2013; 8(10):e76693. PubMed ID: 24116137
[TBL] [Abstract] [Full Text] [Related]
13. Functional role and therapeutic potential of the pim-1 kinase in colon carcinoma.
Weirauch U; Beckmann N; Thomas M; Grünweller A; Huber K; Bracher F; Hartmann RK; Aigner A
Neoplasia; 2013 Jul; 15(7):783-94. PubMed ID: 23814490
[TBL] [Abstract] [Full Text] [Related]
